Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc.
Share · US0906783016 (OTC)
Overview
No Price
Closing Price OTC 27.01.2026: 0,0001 USD
27.01.2026 21:00
Current Prices from Biostar Pharmaceuticals, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
BSPM
USD
27.01.2026 21:00
0,0001 USD
0,00 USD
Company Profile for Biostar Pharmaceuticals, Inc. Share
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
AI Analysis of Biostar Pharmaceuticals, Inc.
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Biostar Pharmaceuticals, Inc.
No AI threads available for this company yet.

Company Data

Name Biostar Pharmaceuticals, Inc.
Company Biostar Pharmaceuticals, Inc.
Website https://biostarpharmaceuticals.com
Primary Exchange OTC UTC
ISIN US0906783016
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Ronghua Wang
Country China
Currency USD
Employees 0,2 T
Address No. 588 Shiji Xi Road, 712000 Xianyang
IPO Date 2008-12-18

Ticker Symbols

Name Symbol
Over The Counter BSPM
More Shares
Investors who hold Biostar Pharmaceuticals, Inc. also have the following shares in their portfolio:
A.S.500 C.N.Z DLA
A.S.500 C.N.Z DLA ETF
CPUK FIN. 21/27 B6
CPUK FIN. 21/27 B6 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026